Certain studies have provided evidence that IL-17 maintains barrier integrity and limits excessive permeability through the IL-17 receptor (IL-17R) adaptor protein Act-1 in a murine inflammatory bowel disease (IBD) model (13). The gene discussed is TRAF3IP2; the disease is inflammatory bowel disease.